These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 34229619

  • 21. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders v. treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data.
    Chapdelaine A, Vasiliadis HM, Provencher MD, Norton PJ, Roberge P.
    Psychol Med; 2023 Oct; 53(14):6570-6582. PubMed ID: 36695038
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of therapist-assisted internet-delivered psychological therapies for PTSD differing in trauma focus in England: an economic evaluation based on the STOP-PTSD trial.
    Penington E, Wild J, Warnock-Parkes E, Grey N, Murray H, Kerr A, Stott R, Rozental A, Andersson G, Clark DM, Tsiachristas A, Ehlers A.
    Lancet Psychiatry; 2024 May; 11(5):339-347. PubMed ID: 38554731
    [Abstract] [Full Text] [Related]

  • 23. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, Kopelman M, James IA, Culverwell A, Pool J, Brand A, Henderson C, Hoare Z, Knapp M, Morgan-Trimmer S, Burns A, Corbett A, Whitaker R, Woods B.
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [Abstract] [Full Text] [Related]

  • 24. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial.
    Ljótsson B, Andersson G, Andersson E, Hedman E, Lindfors P, Andréewitch S, Rück C, Lindefors N.
    BMC Gastroenterol; 2011 Oct 12; 11():110. PubMed ID: 21992655
    [Abstract] [Full Text] [Related]

  • 25. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).
    Everitt HA, Moss-Morris RE, Sibelli A, Tapp L, Coleman NS, Yardley L, Smith PW, Little PS.
    BMC Gastroenterol; 2010 Nov 18; 10():136. PubMed ID: 21087463
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial.
    Hollinghurst S, Peters TJ, Kaur S, Wiles N, Lewis G, Kessler D.
    Br J Psychiatry; 2010 Oct 18; 197(4):297-304. PubMed ID: 20884953
    [Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial.
    Andersson E, Ljótsson B, Smit F, Paxling B, Hedman E, Lindefors N, Andersson G, Rück C.
    BMC Public Health; 2011 Apr 07; 11():215. PubMed ID: 21473754
    [Abstract] [Full Text] [Related]

  • 28. The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial.
    Serfaty M, King M, Nazareth I, Tookman A, Wood J, Gola A, Aspden T, Mannix K, Davis S, Moorey S, Jones L.
    Trials; 2016 Feb 29; 17(1):113. PubMed ID: 26926910
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness analysis of a randomized study of depression treatment options in primary care suggests stepped-care treatment may have economic benefits.
    Yan C, Rittenbach K, Souri S, Silverstone PH.
    BMC Psychiatry; 2019 Aug 05; 19(1):240. PubMed ID: 31382932
    [Abstract] [Full Text] [Related]

  • 30. Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation.
    Wijnen BFM, Oberjé EJM, Evers SMAA, Prins JM, Nobel HE, van Nieuwkoop C, Veenstra J, Pijnappel FJ, Kroon FP, van Zonneveld L, van Hulzen AGW, van Broekhuizen M, de Bruin M.
    Clin Infect Dis; 2019 Feb 01; 68(4):658-667. PubMed ID: 30239629
    [Abstract] [Full Text] [Related]

  • 31. Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial.
    Creswell C, Violato M, Fairbanks H, White E, Parkinson M, Abitabile G, Leidi A, Cooper PJ.
    Lancet Psychiatry; 2017 Jul 01; 4(7):529-539. PubMed ID: 28527657
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M, Miguez S, Dukas B, Onwude O, White S.
    JMIR Mhealth Uhealth; 2021 May 20; 9(5):e26152. PubMed ID: 33872182
    [Abstract] [Full Text] [Related]

  • 33. The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial.
    Brabyn S, Araya R, Barkham M, Bower P, Cooper C, Duarte A, Kessler D, Knowles S, Lovell K, Littlewood E, Mattock R, Palmer S, Pervin J, Richards D, Tallon D, White D, Walker S, Worthy G, Gilbody S.
    Health Technol Assess; 2016 Nov 20; 20(89):1-64. PubMed ID: 27922448
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness analysis of combined cognitive and vocational rehabilitation in patients with mild-to-moderate TBI: results from a randomized controlled trial.
    Howe EI, Andelic N, Fure SCR, Røe C, Søberg HL, Hellstrøm T, Spjelkavik Ø, Enehaug H, Lu J, Ugelstad H, Løvstad M, Aas E.
    BMC Health Serv Res; 2022 Feb 12; 22(1):185. PubMed ID: 35151285
    [Abstract] [Full Text] [Related]

  • 35. The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study.
    Sibelli A, Chalder T, Everitt H, Workman P, Bishop FL, Moss-Morris R.
    Br J Health Psychol; 2017 Nov 12; 22(4):737-762. PubMed ID: 28862389
    [Abstract] [Full Text] [Related]

  • 36. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years.
    Robertson W, Fleming J, Kamal A, Hamborg T, Khan KA, Griffiths F, Stewart-Brown S, Stallard N, Petrou S, Simkiss D, Harrison E, Kim SW, Thorogood M.
    Health Technol Assess; 2017 Jan 12; 21(1):1-180. PubMed ID: 28059054
    [Abstract] [Full Text] [Related]

  • 37. Complaint-Directed Mini-Interventions for Depressive Symptoms: A Health Economic Evaluation of Unguided Web-Based Self-Help Interventions Based on a Randomized Controlled Trial.
    Wijnen BF, Lokman S, Leone S, Evers SM, Smit F.
    J Med Internet Res; 2018 Oct 01; 20(10):e10455. PubMed ID: 30274958
    [Abstract] [Full Text] [Related]

  • 38. Cost-Effectiveness of Virtual Reality Cognitive Behavioral Therapy for Psychosis: Health-Economic Evaluation Within a Randomized Controlled Trial.
    Pot-Kolder R, Veling W, Geraets C, Lokkerbol J, Smit F, Jongeneel A, Ising H, van der Gaag M.
    J Med Internet Res; 2020 May 05; 22(5):e17098. PubMed ID: 32369036
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of habit-based advice for weight control versus usual care in general practice in the Ten Top Tips (10TT) trial: economic evaluation based on a randomised controlled trial.
    Patel N, Beeken RJ, Leurent B, Omar RZ, Nazareth I, Morris S.
    BMJ Open; 2018 Aug 13; 8(8):e017511. PubMed ID: 30104307
    [Abstract] [Full Text] [Related]

  • 40. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
    Barkham M, Saxon D, Hardy GE, Bradburn M, Galloway D, Wickramasekera N, Keetharuth AD, Bower P, King M, Elliott R, Gabriel L, Kellett S, Shaw S, Wilkinson T, Connell J, Harrison P, Ardern K, Bishop-Edwards L, Ashley K, Ohlsen S, Pilling S, Waller G, Brazier JE.
    Lancet Psychiatry; 2021 Jun 13; 8(6):487-499. PubMed ID: 34000240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.